These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21507707)

  • 1. Materials from peptide assembly: towards the treatment of cancer and transmittable disease.
    Branco MC; Sigano DM; Schneider JP
    Curr Opin Chem Biol; 2011 Jun; 15(3):427-34. PubMed ID: 21507707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of vaccines--cancer meets infectious diseases: immune mechanisms. 10-13 April 2003, Semmering, Austria.
    Olszewska W; Openshaw P
    IDrugs; 2003 Jun; 6(6):522-4. PubMed ID: 12861976
    [No Abstract]   [Full Text] [Related]  

  • 3. The Hydrocarbon Staple & Beyond: Recent Advances Towards Stapled Peptide Therapeutics that Target Protein-Protein Interactions.
    Hillman RA; Nadraws JW; Bertucci MA
    Curr Top Med Chem; 2018; 18(7):611-624. PubMed ID: 29773064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.
    Jackson DC; Purcell AW; Fitzmaurice CJ; Zeng W; Hart DN
    Curr Drug Targets; 2002 Apr; 3(2):175-96. PubMed ID: 11958299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembling Peptides and Their Application in the Treatment of Diseases.
    Lee S; Trinh THT; Yoo M; Shin J; Lee H; Kim J; Hwang E; Lim YB; Ryou C
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in supramolecular peptide assemblies as virus mimics for cancer immunotherapy.
    Cai Y; Ran W; Zhai Y; Wang J; Zheng C; Li Y; Zhang P
    Biomater Sci; 2020 Feb; 8(4):1045-1057. PubMed ID: 31637384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
    Chiangjong W; Chutipongtanate S; Hongeng S
    Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy.
    Song H; Su Q; Nie Y; Zhang C; Huang P; Shi S; Liu Q; Wang W
    Acta Biomater; 2023 Mar; 158():535-546. PubMed ID: 36632876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides as cancer vaccines.
    Sundaram R; Dakappagari NK; Kaumaya PT
    Biopolymers; 2002; 66(3):200-16. PubMed ID: 12385038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design for binding peptides in anti-cancer therapy.
    Wang SH; Yu J
    Biomaterials; 2018 Feb; 156():1-15. PubMed ID: 29182932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
    Stephens AJ; Burgess-Brown NA; Jiang S
    Front Immunol; 2021; 12():696791. PubMed ID: 34276688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT.
    Chen R; Fulton KM; Twine SM; Li J
    Mass Spectrom Rev; 2021 Mar; 40(2):110-125. PubMed ID: 31875992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the human immune system to transform the future of global disease prevention and control.
    Koff WC; Schenkelberg T
    Expert Rev Vaccines; 2016 Oct; 15(10):1235-6. PubMed ID: 27010379
    [No Abstract]   [Full Text] [Related]  

  • 14. Self-Assembling Peptides as an Emerging Platform for the Treatment of Metabolic Syndrome.
    Castillo-Díaz LA; Ruiz-Pacheco JA; Elsawy MA; Reyes-Martínez JE; Enríquez-Rodríguez AI
    Int J Nanomedicine; 2020; 15():10349-10370. PubMed ID: 33376325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembling peptides: potential role in tumor targeting.
    Sadatmousavi P; Soltani M; Nazarian R; Jafari M; Chen P
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1089-100. PubMed ID: 21470142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
    Bracci L; La Sorsa V; Belardelli F; Proietti E
    Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.
    Miller MJ; Foy KC; Kaumaya PT
    Discov Med; 2013 Mar; 15(82):166-76. PubMed ID: 23545045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing improved active peptides for therapeutic approaches against infectious diseases.
    Gomes B; Augusto MT; Felício MR; Hollmann A; Franco OL; Gonçalves S; Santos NC
    Biotechnol Adv; 2018; 36(2):415-429. PubMed ID: 29330093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.